# THE-0504 in Patients With Solid Tumors

Source: https://onco.cc/trials/nct07646106/  
OnCo record `nct07646106` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1 trial of THE-0504 run by Thena Biotech S.r.l., now recruiting.

## Summary

THE-0504 in Patients With Solid Tumors is a phase 1 interventional study registered as NCT07646106 by Thena Biotech S.r.l., with 30 participants planned, started 2024-11-13. Conditions recorded: Small Cell Lung Cancer (SCLC), Colorectal Carcinoma (CRC), Gastric Cancer (GC), Triple -Negative Breast Cancer and Pancreas Adenocarcinoma. Interventions recorded: THE-0504.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07646106
- Phase: 1
- Setting: NANOFER-THE-0504: A Trial to Assess the Safety and Tolerability of an Investigational Drug THE-0504 for Patients With Solid Tumors
- Sponsor: Thena Biotech S.r.l.
- Enrolled: 30

## Sources

- ClinicalTrials.gov NCT07646106: https://clinicaltrials.gov/study/NCT07646106

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/), [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Gastric & gastro-oesophageal junction cancer](https://onco.cc/cancers/gastric/), [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/), [Small-cell lung cancer](https://onco.cc/cancers/sclc/)
- drugs: [THE-0504](https://onco.cc/drugs/the-0504/)
- companies: [Thena Biotech](https://onco.cc/companies/thena-biotech/)

---
JSON: https://onco.cc/api/v1/entities/nct07646106.json